Physician profile
Eric J Pearson
NPI 1922092881
$18,690.15
in general payments reported to CMS, 2019-2025
38 companies · $1,924 in 2025
The $1,924 reported for 2025 was more than what 77% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,596 · 2020: $2,077 · 2021: $2,977 · 2022: $3,472 · 2023: $2,584 · 2024: $4,060 · 2025: $1,924.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,349 · Consulting Fee: $2,400 · Travel and Lodging: $818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,349.07 |
| Consulting Fee | $2,400.00 |
| Travel and Lodging | $818.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $11,367.06 | 2019-2025 | Proclaim, Eterna |
| Spinal Simplicity, LLC | $1,548.20 | 2022-2025 | Ha Minuteman G3-R |
| Relievant Medsystems, INC. | $1,293.48 | 2021-2023 | Intracept |
| Medtronic, INC. | $1,033.38 | 2021-2025 | Intellis Adaptivestim, Accurian, Vanta Adaptivestim |
| Boston Scientific Corporation | $801.93 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Mml US, INC. | $429.15 | 2024-2025 | Reactiv8 |
| Foundation Fusion Solutions, LLC | $392.93 | 2021-2024 | |
| Biotronik Nro, INC. | $344.01 | 2025 | Prospera |
| Collegium Pharmaceutical, INC. | $238.91 | 2019-2025 | Belbuca, Xtampza |
| Curonix LLC | $127.55 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertiflex, INC. | $125.24 | 2019 | |
| Amgen INC. | $83.00 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $69.15 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $67.84 | 2019-2020 | |
| Vertos Medical, INC. | $65.29 | 2023-2024 | Mild Device Kit |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $62.77 | 2019-2020 | |
| Stryker Corporation | $62.71 | 2025 | Mild Device Kit |
| Vertex Pharmaceuticals Incorporated | $62.27 | 2024-2025 | |
| Medtronic USA, INC. | $58.37 | 2019-2020 | |
| Grt US Holding, INC. | $57.43 | 2021-2022 | |
| Forte Bio-Pharma LLC | $50.02 | 2023-2024 | Prolate, Nalocet |
| Radius Health, INC. | $41.64 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.25 | 2019 | |
| Horizon Therapeutics Plc | $37.61 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $29.79 | 2023 | Exparel, Zilretta, Iovera |
| Abbvie INC. | $23.50 | 2022 | |
| Scilex Pharmaceuticals INC. | $22.48 | 2019 | |
| Tersera Therapeutics LLC | $21.91 | 2019 | |
| Saluda Medical Americas, INC. | $19.69 | 2024 | Evoke |
| Si-Bone, INC. | $16.13 | 2025 | |
| Globus Medical, INC. | $14.70 | 2025 | Vyrsa V1 |
| Assertio Therapeutics, INC. | $13.02 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.71 | 2021 | |
| Pfizer INC. | $12.60 | 2021 | |
| Daiichi Sankyo INC. | $11.59 | 2019 | |
| Mdd US Operations, LLC | $11.15 | 2019 | |
| Allergan, INC. | $10.89 | 2019 | |
| Lilly USA, LLC | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.